Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

BusinessWeek June 21, 2004 Catherine Arnst	Guard Your Bones Osteoporosis is one of the biggest health risks facing older women. What can be done to help prevent this disease?
Science News November 18, 2006	Science Safari: Bone Health The website of International Osteoporosis Foundation offers information for health professionals and the public about osteoporosis.
American Family Physician March 1, 2001	What You Should Know About Osteoporosis What is osteoporosis?... Who gets osteoporosis?... What are the effects of osteoporosis?... How does my doctor know I have osteoporosis?... How is osteoporosis treated?... How is osteoporosis prevented?... etc.
American Family Physician March 1, 2001 Jeannette E. South-Paul	Osteoporosis: Part I. Evaluation and Assessment Because osteoporosis is usually asymptomatic until a fracture occurs, family physicians must identify the appropriate timing and methods for screening those at risk...
American Family Physician March 1, 2004	Osteoporosis The definition, signs, and who's at risk of getting osteoporosis.
The Motley Fool April 21, 2011 Luke Timmerman	Amgen Passes Key Trial With "Son of Dmab" for Osteoporosis The medical and scientific world will be chirping today about an interesting new finding Amgen has made for treating osteoporosis.
Seasoned Cooking July 2005 Michael Fick	Dem Bones Unless we patients, our doctors, and the whole medical profession change our acts, our aging population, lazier lifestyles, and junk food diets will lead to half of Americans over the age of 50 having osteoporosis or being at high risk for it.
BusinessWeek June 21, 2004 Carol Marie Cropper	Osteoporosis: Men Suffer, Too Bone loss is a bigger threat than prostate cancer for men.
Nutra Solutions July 23, 2007 Ginny Banks	A New Look at Bone Health Although vitamin D and calcium are the mainstay ingredients for osteoporosis prevention, studies show that vitamin K2, phosphorous, magnesium, prebiotics and soy can also play a role.
The Motley Fool February 9, 2011 Luke Timmerman	Amgen Pushes Ahead With "Son of Dmab" for Treating Bones Is there more to Amgen than "Dmab"?
Reactive Reports Issue 51 David Bradley	Cannabinoids and Osteoporosis Researchers have discovered a regulatory mechanism involved in bone loss linked to a chemical receptor in our bodies with a previously unknown function, which could lead to a new treatment.
American Family Physician April 1, 2003 Campion & Maricic	Osteoporosis in Men Osteoporosis in men is now recognized as an increasingly important public health issue. Increased awareness by physicians of risk factors for male osteoporosis -- and early diagnosis and treatment -- are needed to decrease the morbidity and mortality resulting from osteoporotic fractures.
The Motley Fool October 7, 2004 Charly Travers	Amgen's Next Blockbuster An osteoporosis drug could give the company its next big winner. With a P/E back in the mid 20s, the company is valued such that Amgen shareholders should be rewarded in the future if products are successful.
Chemistry World January 24, 2008 Jonathan Edwards	Trio of Papers Cast Doubts on Osteoporosis Treatment Calcium isn't as effective or safe as previously thought, and millions of people may be taking unnecessary preventative treatments.
HHMI Bulletin May 2011 Dan Ferber	Revealing the Biological Complexity of Bones Bones are the body's framework and support, our strongest tissues. Unlike the scaffold of a building, however, bones are anything but inert. They pulse with life and their maintenance requires a surprisingly delicate balancing act.
BusinessWeek January 14, 2010 Rob Waters	Amgen: Strengthening Bones, Weakening Cancer? Regulators may soon approve an Amgen drug, denosumab, for osteoporosis, but the payoff could be in oncology.
American Family Physician March 15, 2001 Jeannette E. South-Paul	Osteoporosis: Part II. Nonpharmacologic and Pharmacologic Treatment Family physicians will frequently encounter patients with osteoporosis, a condition that is often asymptomatic until a fracture occurs...
Delicious Living April 2005 Anne Burnett	Kids need calcium and exercise Researchers suggest that because at least 90 percent of peak bone mass is accrued by the end of adolescence, it is important to optimize bone growth in younger years.
American Family Physician April 1, 2002 Richard Brunader	Radiologic Bone Assessment in the Evaluation of Osteoporosis Because osteoporosis affects a large number of patients with potentially significant morbidity and mortality, it is important to identify patients at risk so that physicians can effectively intervene...
Managed Care July 2006	Physicians' Real Income Continues to Fall Adjusted for inflation, physicians' net income from the practice of medicine declined 7% between 1995 and 2003, according to a national study.
The Motley Fool October 20, 2005 Brian Gorman	Amgen's Drive to Diversify The drugmaker pulled in impressive results with its current portfolio, but a drug in late-stage testing could make the company even more attractive to investors.
The Motley Fool January 28, 2008 Brian Lawler	A Wing and a Prayer for Amgen Amgen announces data from its top pipeline drug candidate. Investors, take note.
The Motley Fool February 26, 2010 Brian Orelli	Boning Up on Pfizer's Drug Fablyn looks OK on paper, but that isn't going to cut it in the crowded osteoporosis market.
The Motley Fool September 20, 2007 Billy Fisher	More Options for Healthy Bones? Novartis and Wyeth might be able to offer alternative treatments for osteoporosis, but the companies have a tough road ahead in this market.
Pharmaceutical Executive March 1, 2011 Jerry Coamey	Engage the Physician! New research shows that gauging the mind of the clinician is crucial to timely uptake of the new diagnostic tools offered by the genomic revolution
Managed Care November 2006 Arthur Lazarus	Expert Opinions Create Liability for Physicians Physicians cannot rely on courts, drug companies, or HMOs to protect their freedom of speech. Their experience and knowledge form the foundation of all medical opinion.
Nurse Practitioner June 2009 Ivy M. Alexander	Pharmacotherapeutic management of osteoporosis and osteopenia The estimated number of individuals with osteoporosis and osteopenia, the precursor to osteoporosis, continues to increase.
Chemistry World May 8, 2007 Lionel Milgrom	Yearly Anti-Osteoporosis Jab Goes Straight to the Bone One injection of a new anti-osteoporosis drug a year can stop osteoporotic bone fractures in post-menopausal women, report researchers. The drug is already marketed by Novartis as Zometa (zoledronic acid) for use in several other disorders.
BusinessWeek December 6, 2004 Catherine Arnst	Cord Blood To The Rescue A study in the Nov. 25 issue of The New England Journal of Medicine confirms that stem cells in blood extracted from the umbilical cords of newborns can help leukemia patients
The Motley Fool February 9, 2010 Brian Orelli	Bone Up On This Potential Blockbuster Amgen's denosumab passes another test on its way to potential blockbuster status.
Food Processing June 2011 Dave Fusaro	How Can Food Processors Help Consumers' Aching and Aging Bones? Beyond vitamin D and phosphate, new ingredients help support calcium.
American Family Physician October 1, 2004 Thomas M. Zizic	Pharmacologic Prevention of Osteoporotic Fractures Of the drugs that have been approved for the prevention or treatment of osteoporosis, the bisphosphonates (risedronate and alendronate) are most effective in reducing the risk of vertebral and nonvertebral fractures.
Pharmaceutical Executive October 1, 2008 Joanna Breitstein	The D-Mab Men Amgen's salvation just may be denosumab. We sit down to talk with the head scientists driving the drug for the multi-billion dollar osteoporosis market
BusinessWeek August 13, 2009 Arlene Weintraub	Amgen's Bone-Loss Drug Faces Marketing Hurdles Amgen is likely to receive FDA approval for denosumab, its new biologic bone-loss drug, but it may be a hard sell against cheaper generics.
Science News October 28, 2006 Janet Raloff	Cola May Weaken Women's Bones New research indicates that, in postmenopausal women, regular consumption of cola-flavored soft drinks may weaken bones.
Science News November 9, 2002 Janet Raloff	Young Women Don't Bone Up on Soy If soy's good for older women, it should similarly benefit women in their 20s -- fortifying their bodies' structural scaffolding during peak bone-building years. But recent research finds zero benefit for younger women.
The Motley Fool October 26, 2010 Brian Orelli	Thank Goodness for Amgen's New Kids The old drugs are dragging down Amgen's growth.
The Motley Fool May 13, 2005 Karl Thiel	Boning Up on New Drugs Are new osteoporosis therapies compelling investments, or is the field too crowded?
The Motley Fool July 30, 2010 Brian Orelli	On the Path to a Blockbuster Amgen's Prolia will be a blockbuster. Eventually.
Managed Care July 2002	Money isn't everything Physicians are fairly happy with their incomes, but unhappy with the number of hours they have to work, as well as with the ancillary duties involved in practicing medicine, according to a survey.
Managed Care April 2002	What's An E-Mail Consultation Worth? The answer depends on whom you ask. A search of news archives turns up two reported experiments with reimbursement of physicians for e-mail communication with patients...
The Motley Fool October 22, 2009 Brian Orelli	Good Luck in 2010, Amgen Just when it looked like Amgen was turning things around the Food and Drug Administration threw a wrench in the biotech's plans for its osteoporosis drug Prolia.
The Motley Fool January 25, 2011 Brian Orelli	2 Keys to Amgen's Continued Success Prolia and Xgeva have to perform.
Nutra Solutions September 1, 2005	Fish to Bone Researchers found diets with a low ratio of omega-6 fatty acids to omega-3 fatty acids minimized the bone loss typically brought on by estrogen deficiency, which is common in post-menopausal females.
The Motley Fool November 19, 2010 Brian Orelli	One Drug, Two Names, Two Wildly Different Prospects Amgen double speaks for increased sales.
Health March 2008 Dorothy Foltz-Gray	How Weighing Too Much Hurts You Being overweight can up your risk for certain diseases.
Managed Care June 2006	Fewer Doctors Contract with Managed Care Although it was stable in the mid-1990s, the proportion of physicians without any managed care contracts rose from 9.2 percent in 2000-2001 to 11.5 percent in 2004-2005, according to a report.
American Journal of Nursing August 2011 Karen Roush	Prevention and Treatment of Osteoporosis in Postmenopausal Women: A Review This article provides an overview of osteoporosis, describes current recommendations for its prevention and treatment, and discusses nursing implications.
The Motley Fool October 19, 2009 Brian Orelli	Still Waiting for Its Blockbuster Amgen announces a Food and Drug Administration delay for its long-awaited osteoporosis drug, Prolia, its treatment for postmenopausal osteoporosis.
Managed Care July 2006	Physician Satisfaction Study Surprises A new study suggests that physicians working in areas where there is an extensive medical infrastructure are less happy with the quality of the care they provide than doctors working elsewhere.